Inotrem, which was founded in 2013, is developing novel immunomodulators that target the TREM-1 pathway. Its lead compound, nangibotide, is a first-in-class anti-TREM-1 peptide that prevents the ...

On Medindia find the complete list of Immunomodulators drugs with their available forms and strength. More information is available on each drug including their price list. We recommend consulting ...

Learn about the new guidelines released by the AGA for pharmacological management of moderate-to-severe ulcerative colitis.